Antisenses to opioid receptors attenuate ATP-gated K+ channel opener-induced antinociception

European Journal of Pharmacology

Volumn 384, Issue 2-3, 1999, Pages 147-152

  Lohmann, Alka B ^a   Welch, Sandra P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antinociception; Antisense ligonucleotide; ATP gated; Intracerebroventricular; K+ channel; Mouse; Opioid

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ADENOSINE TRIPHOSPHATE; ANTISENSE OLIGODEOXYNUCLEOTIDE; DELTA OPIATE RECEPTOR; DIAZOXIDE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; LEMAKALIM; MORPHINE; MU OPIATE RECEPTOR; OPIATE; OPIATE RECEPTOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CALCIUM CELL LEVEL; CHANNEL GATING; CONTROLLED STUDY; MALE; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ADENOSINE TRIPHOSPHATE; ANALGESIA; ANALGESICS; ANIMALS; CROMAKALIM; DIAZOXIDE; ENKEPHALIN, D-PENICILLAMINE (2,5)-; MALE; MICE; MICE, INBRED ICR; MORPHINE; NOCICEPTORS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PAIN; POTASSIUM CHANNELS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0033429082     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00698-6     Document Type: Article

References (28)

1. + channels. Science. 247:1990;852.
2. Bernstein M.A., Welch S.P. Mu opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Mol. Brain Res. 55(2):1998;237-242.
3. Chavkin C. Electrophysiology of opiates and opioid peptides. Pasternak G.W. The Opiate Receptors. 1988;273 Humana Press, NJ.
4. Chien X., Brown G., Pan Y.X., Pasternak G.W. Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a κ-opioid receptor. Eur. J. Pharmacol. 253:1994;R7-R8.
5. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
6. + channel openers: pharmacological effects and future uses. Drugs. 40:1990;785-791.
7. Harris L.S., Pierson A.K. Some narcotic antagonists in the benzomorphan series. J. Pharmacol. Exp. Ther. 143:1964;141-148.
8. Hayes A.G. Mode of action of opioid drugs. Levy J., Budd K. Opioids. 1986;1-7 Royal Society of Medicine Services, London.
9. Lodish H., Baltimore D., Berk A., Zipusky S.L., Matsudaira P., Darnell J. Molecular Cell Biology. 3rd edition:1995;Scientific American Books, New York.
10. + channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides. Eur. J. Pharmacol. 1999;. in press.
11. + channels produces the antinociception and spinal noradrenaline turnover-enhancing effect in mice. Psychopharmacologia. 113:1993;11-14.
12. + channels. Proc. Natl. Acad. Sci. 84:1987;5487-5491.
13. Ocana M., Del Pozo E., Barrios M., Robles M., Baeyens J.M. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur. J. Pharmacol. 186:1990;377-378.
14. + channel blockers antagonize morphine- but not U50,488H-induced antinociception. Eur. J. Pharmacol. 230:1993;203-207.
15. + channel-acting drugs. Br. J. Pharmacol. 114:1995;1296-1302.
16. b, mu and kappa opioid receptors. J. Pharmacol. Exp. Ther. 276:1996;1136-1142.
17. Pedigo N.W., Dewey W.L., Harris L.S. Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J. Pharmacol. Exp. Ther. 193:1975;845-852.
18. + channels. Brain Res. 650:1994;146-148.
19. Reisine T., Pasternak G. Opioid analgesics and antagonists. Hardman J.G., Limbird L.E. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th Edition:1996;521-556 McGraw-Hill, NY.
20. Rossi G.C., Pan Y.-X., Cheng J., Pasternak G.W. Blockade of morphine analgesia by an antisense oligonucleotide against the mu receptor. Life Sci. 52:1994;PL375-PL379.
21. Rossi G.C., Leventhal L., Pan Y.-X., Cole J., Su W., Bodnar R.J., Pasternak G.W. Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6β-glucuronide antinociception. J. Pharmacol. Exp. Ther. 281:1997;109-114.
22. + channel and block neurosecretion. Proc. Natl. Acad. Sci. 87:1990;3489.
23. Sutters K.A., Miaskowski C., Taiwo Y.O., Levine J.D. Analgesic synergy and improved motor function produced by combinations of μ-δ and μ-κ opioids. Brain Res. 530:1990;290-294.
24. Vanderah T.W., Bernstein R.N., Yamamura H.I., Hruby V.J., Porreca F. Enhancement of morphine by a CCKB antagonist in mice is mediated via opioid delta receptors. J. Pharmacol. Exp. Ther. 278:1996;212-219.
25. Vaught J.L., Takemori A.E. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J. Pharmacol. Exp. Ther. 208:1979;86-90.
26. Wang H.Q., Kampine J.P., Tseng L.F. Antisense oligonucleotides to a δ-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered δ-, but not μ-, ε- or κ-opioid receptor agonists in the mouse. Neuroscience. 75:1996;445-452.
27. Welch S.P., Dunlow L.D. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action? J. Pharmacol. Exp. Ther. 267:1993;390-399.
28. Wild K.D., Vanderah T., Mosberg H.I., Porreca F. Opioid δ receptor subtypes are associated with different potassium channels. Eur. J. Pharmacol. 193:1991;135-141.